This content is from: Portfolio New U.S. Rules on Tax Inversions Lack Bite The Treasury’s anti-inversion regulations appear to be more about politics than stamping out corporate tax shelters abroad. By Anne Szustek October 13, 2014
This content is from: Corner Office To Combat Inversions, It May Be Time to Raise Some Taxes Stan Druckenmiller believes inversions present an opportunity to pursue broader reform of the U.S. tax system, tax hikes included. By Aaron Timms July 24, 2014
This content is from: Portfolio Daily Agenda: Fiduciary Rule, Tax Inversion Regs Shake Up Financial Services Treasury rules threaten M&A boom as Pfizer deal craters; Labor Department slaps retail advisers with fiduciary rule; German bond yields remain negative; Cruz, Sanders take Wisconsin. By Andrew Barber April 06, 2016
This content is from: Portfolio Allergan-Pfizer Merger Gives Pharma a Growth Injection The $160 billion all-stock deal is the largest-ever tax inversion and pharmaceutical sector merger. By Anne Szustek December 16, 2015
This content is from: Portfolio Deals of the Year 2014: Medtronic, Covidien Home in on Tie-Up With their pending $46.8 billion merger, the two medical device makers find themselves swept up in the corporate tax inversion debate. By Kaitlin Ugolik December 10, 2014
This content is from: Portfolio Daily Agenda: Global Sentiment Shifts to Risk-Off Stock markets decline in Europe and Asia; Petrobras scandal in Brazil widens; Treasury issue rules to rein-in tax inversions; German data weak; India cuts rates. By Andrew Barber April 05, 2016
